Cromos™ Pharma begins operations in Belarus
MOSCOW–(Marketwired – Jun 24, 2013) – Cromos Pharma, a full service regional contract research organization (CRO), announced today that it has begun operations in the Republic of Belarus.
“When it comes to clinical research, Belarus has many attractive attributes,” noted Dr. Vladimir Bogin, Chief Executive Officer of Cromos Pharma. “Belarus has a developed healthcare system, well-trained medical professionals with good knowledge of ICH/GCP and standards of care that are comparable to European medical practice,” continued Dr. Bogin.
“Recent legislative concessions allow for a significant increase in the reimbursement of study teams. This signifies a substantial shift in state policy towards clinical research and has sparked a renewed interest in clinical trials by both medical centers and investigators,” said Cromos Pharma’s Managing Director, Andrey Tarakanov, MD.
“Recent addition of Georgia and now of Belarus to its geographic footprint will allow Cromos Pharma to compete for even larger multi-center, international clinical trials,” concluded Dr. Bogin.
Cromos Pharma has recently published a white paper which provides comprehensive updates on the Belarusian regulatory changes along with a brief overview of its healthcare system.
